Notice Information
Notice Title
Nucleic Acid Testing Services
Notice Description
NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT's existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All in vitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. The intended use of the assays must include use on human blood, stem cell, and tissue donors. Great Britain (GB) will continue to recognise CE marking under the IVDD or IVDR until devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) without the need for changes to PULSE. NHSBT are looking for a fully integrated, high throughput, automated Nucleic Acid Testing (NAT) screening system which can detect HCV RNA, HIV-1 RNA, HIV-2 RNA, HBV DNA, HEV RNA, and WNV RNA. NAT Screening will be performed by NHSBTs two testing sites in England at Manchester and Bristol (Filton). Samples from blood donors donations will be pooled prior to screening therefore pooling equipment is also required as part of the solution. Samples from stem cell and living tissue donors will be screened as individual donations and therefore not pooled. Throughput requirements: HCV RNA, HIV-1 RNA, HIV-2 RNA, HBV DNA, HEV RNA: 1,520,000 samples per year WNV RNA: 48,000 samples per year At a minimum, HCV, HIV, and HBV must be multiplexed KEG approval is a mandatory requirement for this opportunity, in-line with the requirements of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).NHSBT will seek to understand the status of assays which would be offered with regards to KEG within the Tender. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-dd6962dd-c8bf-47bd-ac40-6b677160a5bd
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/f0a1f255-f839-4709-9b73-0bfc6c6af3ef
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure (above threshold)
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
48 - Software package and information systems
71 - Architectural, construction, engineering and inspection services
-
- CPV Codes
33124000 - Diagnostics and radiodiagnostic devices and supplies
33124110 - Diagnostic systems
33141625 - Diagnostic kits
33696200 - Blood-testing reagents
33696500 - Laboratory reagents
48921000 - Automation system
71900000 - Laboratory services
Notice Value(s)
- Tender Value
- £50,000,000 £10M-£100M
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 6 Oct 20232 years ago
- Submission Deadline
- 7 Dec 2023Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 28 Jul 2024 - 30 Jul 2034 Over 5 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Not Specified
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS BLOOD AND TRANSPLANT
- Contact Name
- Tennille Madigan
- Contact Email
- tennille.madigan@nhsbt.nhs.uk
- Contact Phone
- +447795483583
Buyer Location
- Locality
- BRISTOL
- Postcode
- BS34 7QH
- Post Town
- Bristol
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK5 West of England
- Small Region (ITL 3)
- TLK52 Bath & North East Somerset and South Gloucestershire
- Delivery Location
- Not specified
-
- Local Authority
- South Gloucestershire
- Electoral Ward
- Filton
- Westminster Constituency
- Filton and Bradley Stoke
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/f0a1f255-f839-4709-9b73-0bfc6c6af3ef
6th October 2023 - Opportunity notice on Contracts Finder
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-dd6962dd-c8bf-47bd-ac40-6b677160a5bd-2023-10-06T15:43:40+01:00",
"date": "2023-10-06T15:43:40+01:00",
"ocid": "ocds-b5fd17-dd6962dd-c8bf-47bd-ac40-6b677160a5bd",
"language": "en",
"initiationType": "tender",
"tender": {
"id": "CF-1919200D0O000000rwimUAA",
"title": "Nucleic Acid Testing Services",
"description": "NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT's existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All in vitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. The intended use of the assays must include use on human blood, stem cell, and tissue donors. Great Britain (GB) will continue to recognise CE marking under the IVDD or IVDR until devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) without the need for changes to PULSE. NHSBT are looking for a fully integrated, high throughput, automated Nucleic Acid Testing (NAT) screening system which can detect HCV RNA, HIV-1 RNA, HIV-2 RNA, HBV DNA, HEV RNA, and WNV RNA. NAT Screening will be performed by NHSBTs two testing sites in England at Manchester and Bristol (Filton). Samples from blood donors donations will be pooled prior to screening therefore pooling equipment is also required as part of the solution. Samples from stem cell and living tissue donors will be screened as individual donations and therefore not pooled. Throughput requirements: HCV RNA, HIV-1 RNA, HIV-2 RNA, HBV DNA, HEV RNA: 1,520,000 samples per year WNV RNA: 48,000 samples per year At a minimum, HCV, HIV, and HBV must be multiplexed KEG approval is a mandatory requirement for this opportunity, in-line with the requirements of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).NHSBT will seek to understand the status of assays which would be offered with regards to KEG within the Tender. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk",
"datePublished": "2023-10-06T15:43:40+01:00",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "33124000",
"description": "Diagnostics and radiodiagnostic devices and supplies"
},
"additionalClassifications": [
{
"scheme": "CPV",
"id": "71900000",
"description": "Laboratory services"
},
{
"scheme": "CPV",
"id": "48921000",
"description": "Automation system"
},
{
"scheme": "CPV",
"id": "33696200",
"description": "Blood-testing reagents"
},
{
"scheme": "CPV",
"id": "33141625",
"description": "Diagnostic kits"
},
{
"scheme": "CPV",
"id": "33696500",
"description": "Laboratory reagents"
},
{
"scheme": "CPV",
"id": "33124110",
"description": "Diagnostic systems"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"postalCode": "BS34 7QH"
},
{
"countryName": "United Kingdom"
}
]
}
],
"value": {
"amount": 50000000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure (above threshold)",
"tenderPeriod": {
"endDate": "2023-12-07T18:00:00Z"
},
"contractPeriod": {
"startDate": "2024-07-29T00:00:00+01:00",
"endDate": "2034-07-30T23:59:59+01:00"
},
"suitability": {
"sme": false,
"vcse": false
},
"mainProcurementCategory": "services",
"documents": [
{
"id": "1",
"documentType": "tenderNotice",
"description": "Opportunity notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/f0a1f255-f839-4709-9b73-0bfc6c6af3ef",
"datePublished": "2023-10-06T15:43:40+01:00",
"format": "text/html",
"language": "en"
}
]
},
"parties": [
{
"id": "GB-CFS-251386",
"name": "NHS Blood and Transplant",
"identifier": {
"legalName": "NHS Blood and Transplant"
},
"address": {
"streetAddress": "Bristol",
"locality": "Bristol",
"postalCode": "BS34 7QH",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Tennille Madigan",
"email": "tennille.madigan@nhsbt.nhs.uk",
"telephone": "+447795483583"
},
"roles": [
"buyer"
]
}
],
"buyer": {
"id": "GB-CFS-251386",
"name": "NHS Blood and Transplant"
}
}